Graphite Bio Inc logo

Graphite Bio Inc

South San Francisco, CA

Graphite Bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases. The company’s platform harnesses the natural cellular process of homology directed repair (HDR) and targeted DNA integration to precisely repair genetic defects at their source. Graphite Bio is leveraging its differentiated platform to advance a portfolio of transformative genetic treatments with potential for saving and dramatically improving patients’ lives

graphitebio.com

Company Details

Founded

2020

Employees

Between 100 - 500 employees

Raised

$195,749,984

Headquarters Location

South San Francisco, CA

Public

Yes

Acquired

No

CEO

Kimberlee C. Drapkin

Founders

Daniel Dever
Matthew Porteus

Company Collections

These are collections Graphite Bio Inc is a part of. Click on the collection name to view similar companies.

Graphite Bio Inc's Tech Stack

Company Collections For Graphite Bio Inc